Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 876.40 INR
Change Today -8.35 / -0.94%
Volume 12.3K
ASTR On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

astrazeneca pharma india ltd (ASTR) Snapshot

Open
889.75
Previous Close
884.75
Day High
910.00
Day Low
865.00
52 Week High
06/23/14 - 1,245
52 Week Low
12/17/14 - 781.00
Market Cap
21.9B
Average Volume 10 Days
14.9K
EPS TTM
-0.20
Shares Outstanding
25.0M
EX-Date
07/9/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ASTRAZENECA PHARMA INDIA LTD (ASTR)

Related News

No related news articles were found.

astrazeneca pharma india ltd (ASTR) Related Businessweek News

No Related Businessweek News Found

astrazeneca pharma india ltd (ASTR) Details

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. The company primarily offers products in the areas of cardiovascular and metabolic diseases; oncology; respiratory, inflammation, and autoimmunity; and infection, neuroscience, and gastrointestinal diseases. It also provides clinical trial services on pharmaceutical products. The company was founded in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

1,559 Employees
Last Reported Date: 09/11/14
Founded in 1979

astrazeneca pharma india ltd (ASTR) Top Compensated Officers

Managing Director, Director, Member of Share ...
Total Annual Compensation: 12.3M
Compensation as of Fiscal Year 2014.

astrazeneca pharma india ltd (ASTR) Key Developments

AstraZeneca Pharma India Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

AstraZeneca Pharma India Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales/income from operations (net of exercise duty) was INR 1,081.233 million against INR 1,188.792 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 145.118 million against INR 0.609 million a year ago. Loss from ordinary activities before tax was INR 134.090 million against profit from ordinary activities before tax of INR 15.179 million a year ago. Net loss for the period was INR 134.090 million against net profit for the period of INR 15.179 million a year ago. Basic and diluted loss per share was INR 5.36 against basic and diluted earnings per share of INR 0.61 a year ago. For the nine months, the company reported net sales/income from operations (net of exercise duty) was INR 3,482.451 million against INR 3,595.988 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 634.718 million against INR 52.233 million a year ago. Loss from ordinary activities before tax was INR 589.692 million against profit from ordinary activities before tax of INR 25.888 million a year ago. Net loss for the period was INR 589.692 million against net profit for the period of INR 20.599 million a year ago. Basic and diluted loss per share was INR 23.59 against basic and diluted earnings per share of INR 0.82 a year ago.

AstraZeneca Pharma India Limited, Board Meeting, Feb 11, 2015

AstraZeneca Pharma India Limited, Board Meeting, Feb 11, 2015. Agenda: To consider and approve the unaudited financial results of the company for the quarter ended December 31, 2014.

AstraZeneca Pharma India Limited to Report Q3, 2015 Results on Feb 11, 2015

AstraZeneca Pharma India Limited announced that they will report Q3, 2015 results on Feb 11, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ASTR:IN 876.40 INR -8.35

ASTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ASTR.
View Industry Companies
 

Industry Analysis

ASTR

Industry Average

Valuation ASTR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.8x
Price/Book 17.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PHARMA INDIA LTD, please visit www.astrazenecaindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.